IPP Bureau
Biohaven licenses Taldefgrobep Alfa from Bristol Myers Squibb
By IPP Bureau - February 25, 2022
It is a Phase 3 ready anti-myostatin adnectin for Spinal Muscular Atrophy (SMA).
Sanofi and GSK to seek regulatory authorization for Covid-19 vaccine
By IPP Bureau - February 24, 2022
100% efficacy against severe Covid-19 disease and hospitalizations
Aadi Bioscience launches Fyarro in the USA
By IPP Bureau - February 24, 2022
Fyarro added to NCCN guidelines as the only preferred mTOR inhibitor to treat malignant PEComa
Novavax ships first consignment of Covid-19 vaccine to European countries
By IPP Bureau - February 24, 2022
The first wave of shipments includes several countries, such as Germany, France and Austria
Study details Proof-of-Concept for Covid-19 detection via saliva screening
By IPP Bureau - February 24, 2022
Methodology developed by QIMR Berghofer researchers utilizing the Agilent Cary 630 FTIR
Elanco announces appointment of Rajeev (Bobby), Modi as Executive VP, U.S. Pet Health
By IPP Bureau - February 24, 2022
Modi holds a bachelor's degree in Chemical Engineering from University of Cincinnati and a master’s degree in Marketing, Management Strategy and Finance from Northwestern’s Kellogg School of Management
Philips on track with its ESG commitments
By IPP Bureau - February 24, 2022
Circular revenues already at 16% of sales, driven by healthcare informatics and services to enhance medical equipment uptime and utilization, system and software upgrades for enhanced functionality and extended lifetime and reusing refurbished parts and systems
Ruby Chandy elected to the board of Thermo Fisher Scientific
By IPP Bureau - February 24, 2022
Chandy was the president of the Industrial Division of Pall Corporation, a leading supplier of filtration, separation, and purification technologies. Previously, she was chief marketing officer at the Dow Chemical Company and Rohm and Haas Corporation
Experts say extended day prescription refills for hypertension can be a game-changer
By IPP Bureau - February 24, 2022
The recently released WHO guideline on hypertension treatment (2021), recommends that patients with stable blood pressure can be asked to visit clinics at 3-6 month intervals as an important strategy to improve hypertension control
Experts point out key issues for vision loss at ASSOCHAM meet
By IPP Bureau - February 24, 2022
Cataract is the most common cause of blindness in India, and that diabetes is to be blamed for the massive number of damaged eyes
Fortis, Shalimar Bagh opens Mother and Child Care wing
By IPP Bureau - February 24, 2022
The new wing will cater to all aspects of mother and child health by offering comprehensive, end to end services in radiology, diagnostics, obstetric surgeries and an exclusive gynaecology emergency section
Azelis expands partnership with Roquette to strengthen India presence
By IPP Bureau - February 24, 2022
This new mandate builds upon and strengthens Azelis and Roquette’s global strategic partnership which spans multiple regions and industries.
Cadila Healthcare is now Zydus Lifesciences
By IPP Bureau - February 24, 2022
Zydus unveils its ‘innovation and care’ centric corporate brand identity
Omicron sublineage BA.2 a Variant of Concern: WHO
By IPP Bureau - February 23, 2022
As part of its on-going work to track variants, WHO's Technical Advisory Group on SARS-CoV-2 Virus Evolution (TAG-VE) discussed the latest evidence on the Omicron variant of concern
MicroLumix’ GermPass kills Covid-19 virus in five seconds
By IPP Bureau - February 23, 2022
New biotechnology product aims to be world's fastest automatic sanitary solution
